Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

San Diego Convention Center

Jun 16, 2024 7:00 AM - Jun 20, 2024 3:00 PM

111 W Harbor Drive, , San Diego, CA 92101 , USA

DIA 2024 Global Annual Meeting

Join us at the premier life sciences conference, celebrating our 60th anniversary! Discover 180+ sessions on Cell and Gene Therapy, Decentralized Clinical Trials, AI, ICH, and more. Get ready to tackle challenges, improve skills, network, and drive change for healthcare at DIA2024.

Supporting Regulatory Convergence and Reliance Through a Pharmaceutical Quality Knowledge Management Capability

Session Chair(s)

Theresa  Mullin, PHD

Theresa Mullin, PHD

Associate Center Director - CDER, FDA, United States

The session will provide an update on ICMRA's Pharmaceutical Quality Knowledge Management project, including an overview of learnings from the pilots on collaborative assessment of post-approval changes and hybrid inspections by multiple authorities.

Learning Objective : Describe the various workstreams of the ICMRA PQKM project, and their potential to support increased regulatory convergence and reliance with regards to product quality assessments and inspections; Summarise learnings arising from the ICMRA pilots on collaborative assessment of post-approval changes and hybrid inspections; Discuss potential for expansion and operationalization of the pilots.

Speaker(s)

Sean  Barry, PHD

Sean Barry, PHD

Senior Pharmaceutical Assessor , Health Products Regulatory Authority (HPRA), Ireland

Collaborative Assessment Pilot: Regulators’ Perspective

Sau  Lee, PHD

Sau Lee, PHD

Deputy Super Office Director, OPQ, CDER, FDA, United States

Collaborative Assessment Pilot: Regulators’ Perspective

Stelios  Tsinontides, PHD, MA

Stelios Tsinontides, PHD, MA

VP, QMS, Transformation, and External Advocacy, Merck, United States

Collaborative Hybrid Inspection Pilot (CHIP): Regulator's Perspective

Brendan  Cuddy, MSC

Brendan Cuddy, MSC

Lead Scientific Officer, European Medicines Agency, Netherlands

Collaborative Hybrid Inspection Pilot (CHIP): Regulator's Perspective

Susanne  Ausborn, PHD

Susanne Ausborn, PHD

Global Head International Regulatory Policy, Roche, Switzerland

Pilot Programs: Industry's Perspective

Srivdya  Srikant, MS

Srivdya Srikant, MS

Director, Global Regulatory Affairs- CMC, Gilead Sciences, United States

Pilot Programs: Industry's Perspectives

Evdokia  Korakianiti, PHARMD

Evdokia Korakianiti, PHARMD

Head of Quality and Safety of Medicines, European Medicines Agency, Netherlands

Panel Discussion: Pilot Programs

Yasuhiro  Kishioka, PHD

Yasuhiro Kishioka, PHD

Review Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Panel Discussion: Pilot Programs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.